Abstract. microRNAs (miRNAs) are aberrantly expressed in cancer. An enzyme essential for miRNA processing is Dicer, whose expression is deregulated in diverse types of cancer and correlates with tumor progression. However, whether the regulation of Dicer expression affects tongue squamous cell carcinoma is unknown. In the present study, we investigated how silencing the expression of Dicer alters cell proliferation, cell cycle patterns, and cell migration and invasion in the Tca-8113 tongue squamous cell carcinoma cell line. Dicer expression levels were determined using quantitative PCR and western blot analysis in normal oral gingival epithelial cells and in two tongue squamous cell carcinoma lines, Tca-8113 and UM-1. Tca-8113 cells were transfected with Dicer siRNA or a negative control siRNA. Cell proliferation was determined using the MTT assay and the cell cycle was examined using flow cytometry. Cell migration and invasion changes were evaluated using wound-healing, adherence and Transwell assays. Dicer was expressed at lower levels in the tongue squamous cell carcinoma cell lines Tca-8113 and UM-1 compared to normal gingival epithelial cells, and less Dicer was expressed in UM-1 cells compared to Tca-8113 cells. Notably, Tca-8113 cells transfected with Dicer siRNA had significantly higher proliferative and invasive abilities than cells transfected with the negative control siRNA or nontransfected cells. Silencing Dicer may promote the progression of tongue squamous cell carcinoma. Dicer could serve a promising biomarker and a potential therapeutic target for tongue squamous cell carcinoma.
Introduction microRNAs (miRNAs) are small non-coding RNAs (~22 nt) that regulate the expression of target genes by promoting RNA cleavage or inhibiting RNA translation. Dicer, a key member of the RNase III family, is an essential component of the miRNA-processing machinery in the cytoplasm in which the precursors of miRNAs are processed by Dicer into mature miRNAs (1) . The abnormal expression of miRNAs is associated with the development and progression of cancer (2, 3) . Dicer is aberrantly expressed in different types of cancer, and, being an upstream regulator of miRNAs, Dicer may affect the behavior of cancer by altering the expression spectrum of miRNAs.
The miRNA expression spectrum varies with cancer types, although in most types of cancer miRNAs are globally downregulated (4) . However, whether the reduction in miRNA expression promotes cancer development or merely reflects the state of undifferentiated tumors is unclear. Markedly, tumor behaviors have been reported to be altered after silencing Dicer expression in vitro (5, 6) , but little evidence is available regarding the expression patterns of Dicer in tongue squamous cell carcinoma or the influence of knocking down Dicer expression on this type of cancer. In the present study, we first compared Dicer protein and mRNA expression between 2 carcinoma cell lines, Tca-8113 (7, 8) and UM-1 (8, 9) and normal gingival epithelial cells. We found that Dicer protein levels were lower in the carcinoma cells than in normal cells, and that Dicer expression was the lowest in the highly aggressive UM-1 cancer cells. Thus, we knocked down the expression of Dicer in Tca-8113 cells using siRNA transfection in vitro to investigate how disrupting Dicer-dependent maturation of miRNAs affects cell proliferation, cell cycle patterns and cell migration and invasion to affect cancer development. One day before transfection, Tca-8113 cells were re-plated in 6-well plates to obtain 50-80% confluence on the day of transfection. A complex of siRNAs (100 nM) and 5 µl Lipofectamine RNAiMAX reagent (Invitrogen) was added into each well according to the manufacturer's instructions. Transfection efficiency was estimated 6 h later using fluorescence microscopy. Transfections were performed in triplicate for each treatment.
Materials and methods

Cell
Real-time quantitative PCR analysis. Total RNA was extracted using TRIzol reagent (following the manufacturer's instructions; Invitrogen) from normal gingival epithelial cells, Tca-8113 cells, UM-1 cells and 3 groups of Tca-8113 cells: cells transfected with Dicer-siRNA and negative-control siRNA and non-transfected cells. From the total RNA, cDNAs were synthesized using the Takara PrimeScript RT reagent (Perfect Real-Time kit) under reaction systems for 500 ng and 10 µl. The qPCR primer sequences used in the study were: Dicer forward primer, 5'-TGTGGGGAGAGGGCTGCTCA-3' and reverse primer, 5'-GGCACAGGGCCTTTTCCCGA-3'; GAPDH forward primer, 5'-AAGGTGAAGGTCGGAGTCA AC-3' and reverse primer, 5'-GGGGTCATTGATGGCAACA ATA-3' .
GAPDH was used as an internal control. PCR was performed in triplicate in a total reaction volume of 20 µl, which included 10 µl of the 2X reaction mix, 0.4 µl of 50X Rox, 3 µl of primer (2 µM MTT assay. Cells were plated in 96-well plates at a density of 2,000 cells/well in 100 µl of culture medium and maintained until they adhered before carrying out transfections. After transfection with siRNAs at 37˚C for 4 h, cells were incubated with 20 µl of MTT solution (5 mg/ml) for 24 and 48 h. At the end of the incubation, media were aspirated, 200 µl of DMSO was added to each well and the absorbance at 570 nm was measured. Mean absorbance from 3 replicate wells was determined, and cell viability was defined as (absorbance of treated cells)/(absorbance of control cells).
Cell cycle analysis. The 3 groups of cells were harvested 24 h after transfection with siRNA; cells were fixed overnight with 70% cold ethanol, washed twice with cold PBS, and then incubated in RNase A (10 mg/ml) for 1 h at 37˚C. Propidium iodide (PI) 100 µg/ml was added and mixed for 30 min and then the cells were used for flow cytometric analysis.
Cell adhesion test, Erasion Trace test and Transwell cellinvasive assay.
Matrigel (50 µl) diluted with RPMI-1640 (1:5) was added to 96-well plates and maintained at 4˚C overnight. The next day, plates were sealed at 37˚C for 1 h after replacing the fluid in the wells with 100 µl of RPMI-1640 containing 1% BSA. Experimental and control cells were plated without serum in the wells and incubated for 1 h, and the cells that did not adhere to the Matrigel were washed off using PBS. Next, 20 µl of MTT with 100 µl of RPMI-1640 was added to each well and incubated for 4 h. At the end of the incubation, the solution was aspirated, 200 µl of DMSO was added to each well, and the absorbance at 570 nm was measured; mean absorbance was determined from 3 replicate wells. When attached, transfected cells were 80% confluent in 24-well plates, the culture medium was replaced with basic medium, and a 100-µl pipette tip was used to scrape cells in the middle of the wells. The scraped cells were washed off using PBS and the plates were placed in a 37˚C incubator for 48 h. Distances migrated by cells across the middle of the wells were calculated by examining cells from 5 fields selected randomly under the microscope.
To the top chamber of a Transwell chamber, 30 µl of Matrigel diluted with RPMI-1640 (1:3) was added and maintained at 37˚C and allowed to polymerize. Transfected cells were trypsinized and adjusted to a concentration of 5x10 5 cells/ml in RPMI-1640, and 200 µl of the resuspended cell solution was added to the top chamber above the Matrigel. The bottom chamber was filled with 600 µl of RPMI-1640 containing 10% serum. The Transwell plates were incubated at 37˚C for 24 h and then the top chamber was removed and the Matrigel with unmigrated cells was gently scraped with a wet cotton swab. Cells were stained with 0.1% crystal violet for 5 min, washed with PBS to remove excess stain, and the average number of cells per field that had migrated was quantified under the microscope. The assay was repeated using the Transwell chamber without Matrigel.
Statistical analysis. SPSS-13.0 software, variance analysis, and 2 independent t-tests were used to analyze the differences in Dicer expression between the 3 types of cells and to evaluate the biological responses in treated and control cells.
Results
Dicer is downregulated in tongue squamous cell carcinoma cell lines. The relative expression levels of Dicer mRNA and protein were evaluated in normal oral gingival epithelial cells and 2 tongue squamous cell carcinoma cell lines, Tca-8113 and UM-1 cells (Figs. 1 and 2 ). Real-time qPCR showed that more Dicer mRNA was present in normal oral gingival cells than in Tca-8113 cells (P=0.020) and UM-1 cells (P=0.002). Western blotting showed that the amount of Dicer protein was significantly less in the 2 tongue squamous cell lines than in normal gingival epithelial cells (P=0.000 for both Tca-8113 and UM-1 cells). Dicer mRNA levels in Tca-8113 and UM-1 were not significantly different (P= 0.166), but the amount of Dicer protein in the highly aggressive carcinoma cell line UM-1 was less than in Tca-8113 cells (P=0.000). Lastly, these results were further confirmed by the immunohistochemical staining for Dicer in the cells.
RNAi knocks down Dicer expression in Tca-8113 cells.
FAM-labeled siRNAs were transfected into Tca-8113 cells and 6 h later the transfection efficiency was determined using fluorescence microscopy. Approximately 80% of the transfected cells emitted green fluorescence upon excitation. Total cellular RNAs from Dicer siRNA-transfected cells and control cells (negative-control-siRNA transfected and non-transfected) were extracted 24 h after transfection. RT-PCR showed that the level of Dicer mRNA in the Dicer-siRNA group was significantly lower than in the 2 control groups (P=0.000). Similarly, western blotting demonstrated that the Dicer protein amount was substantially lower in the Dicer-siRNA group than in the 2 control groups at 24 and 48 h after transfection (Fig. 3) .
Silencing Dicer promotes cell proliferation and cell cycle.
To investigate the impact of Dicer on the proliferative capacity of cells, we measured the effects of Dicer-siRNA transfection on cell proliferation using the MTT assay and on cell cycle progression by using flow cytometry following PI staining. The MTT assay (Fig. 4 ) demonstrated that transfection with DicersiRNA increased Tca-8113 cell proliferation at 24 and 48 h after transfection relative to the 2 controls (negative-control siRNA transfected and non-transfected cells). Moreover, cell cycle analysis revealed that in Tca-8113 cells transfected with Dicer-siRNA, the rate of S+G2 phases increased sharply accompanied by a reduction in G1 phase ( Fig. 5 ; Table I ), indicating that the depletion of Dicer accelerated the cell cycle (to S and G2 phases).
Silencing Dicer expression increases cell migration and invasion.
To examine how silencing Dicer expression affects the migratory and invasive abilities of Tca-8113 cells, we quantified 
Discussion
Dicer, a member of RNase III family essential for miRNA processing, is known to be associated with cancer. Dicer is upregulated in prostate, colorectal cancer and lung squamous cell carcinoma (1,10-14) , and is downregulated in hepatocellular carcinoma, gastric, breast and ovarian cancer (15) (16) (17) (18) .
Dicer is mis-expressed in different types of cancer, and Dicer expression changes are biomarkers of poor prognostics for cancer patients.
Cancer can be promoted or suppressed by miRNAs (19) . In certain types of cancer, miRNAs are upregulated (20) , but in most cancers the miRNAs are globally downregulated, and this downregulation plays a key role in the phenotypic transformation of cancer (4). Since Dicer is an upstream regulator of miRNAs, the mis-expression of Dicer in cancer can partly explain the abnormal expression of miRNAs in the cancer cells, and several studies have demonstrated changes in cancer behavior after silencing Dicer both in vivo and in vitro. For instance, knocking down Dicer in breast cancer can lead to a more malignant and invasive phenotype in vitro (21) . Moreover, in animal studies, silencing Dicer in the mouse model of lung cancer using K-Ras promoted the development of the cancer, and suppressing the expression of Dicer contributed to liver cancer in mice (22, 23) . However, no evidence thus far has suggested a role of Dicer in tongue squamous cell carcinoma.
We found that Dicer was expressed at lower levels in 2 cell lines of tongue squamous cell carcinoma (Tca-8113 and UM-1 cells) compared to normal gingival epithelial cells, which supports the theory that miRNAs are downregulated in cancer due to the suppression of Dicer expression. Our results further link Dicer downregulation and the potential impairment of miRNA processing with the transformation of tumor cells; we also demonstrated that depletion of Dicer, a key component in the miRNA processing machinery in cells, enhanced malignant transformation of tongue squamous carcinoma cells. Specifically, knocking down Dicer in Tca-8113 cells significantly increased the proliferative ability, G1 arrest and invasiveness of the cells.
Collectively, our results suggest that Dicer functions as an indirect tumor suppressor, as silencing Dicer expression makes cancer cells more malignant. Although the mechanism of this transformation remains elusive, the present study suggests that rectifying the aberrant expression of Dicer could be one approach in treating tongue squamous cell carcinoma.
